Peter Fratarcangelo
Peter Fratarcangelo has been devoted to medical research for the last 40 years. As Associate Director of new drug development at both Pfizer and Richardson-Vicks (now Proctor & Gamble) and as CEO of his successful medical research company, Inernational HealthCare, he has successfully guided the development and FDA approval of over 35 new drugs and medical devices now on the market. He has patented medical devices as well as published and presented over 12 articles in major peer reviewed journals and at Global Medical Conferences. He has a BS, MSc, and PhD in Operations Research (the use of advanced analytical methods to help make better decisions).
His life long experience and expertise on how best to collect and use all data before making a major decision to move forward to market and new drug or device is what drove him to write this book. He applies this knowledge o how to approach the problems we all face and hoe best to implement a solution that will benefit all of us.
His life long experience and expertise on how best to collect and use all data before making a major decision to move forward to market and new drug or device is what drove him to write this book. He applies this knowledge o how to approach the problems we all face and hoe best to implement a solution that will benefit all of us.
Interviews with Peter Fratarcangelo»See all
Peter Fratarcangelo joins Jim Blasingame to talk about the fundamentals of successful healthcare reform, with preclude the mandates that are part of Obamacare.
Peter Fratarcangelo joins Jim Blasingame to talk about how his company provides drug research and support to the American drug industry and the FDA.
